Clinical Trials Directory

Trials / Unknown

UnknownNCT03475719

A Clinical Trial to Evaluate the Safety and Pharmacokinetic

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristic After Administration of Fixed-dose Combination or Loose Combination of HUG186 in Healthy Adult Male or Menopausal Female Volunteers

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Huons Co., Ltd. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

A phase 1 clinical trail to evaluate the safety and pharmacokinetic characteristic after administration of fixed-dose combination or loose combination of HUG186 in healthy adult male or menopausal female volunteers

Conditions

Interventions

TypeNameDescription
DRUGHUG186-B and HUG186-DBazedoxifene acetate 22.6mg, Cholecalciferol 8.0mg(=800IU)
DRUGHUG186Combination of Bazedoxifene acetate 22.6mg and Cholecalciferol 8.0mg(=800IU)

Timeline

Start date
2018-01-11
Primary completion
2018-02-11
Completion
2018-04-30
First posted
2018-03-23
Last updated
2018-03-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03475719. Inclusion in this directory is not an endorsement.

A Clinical Trial to Evaluate the Safety and Pharmacokinetic (NCT03475719) · Clinical Trials Directory